International research led by University College London (UCL) as part of the ‘Cities Changing Diabetes’ partnership programme challenges current scientific understanding of the rapid rise of diabetes in cities. The findings suggest that in cities around the world, social and cultural factors play a far more important role in the spread of the epidemic than previously thought.
More than two thirds of the world’s 400 million people with diabetes live in urban areas.1,2 The year-long study for Cities Changing Diabetes, a unique public-private-academic partnership, sought to better understand what makes people vulnerable to type 2 diabetes in cities in order to inform solutions for one of the most pressing modern-day public health challenges. To explore this complex issue, more than 550 interviews were undertaken with at-risk and diagnosed people in five major cities – Copenhagen, Houston, Mexico City, Shanghai and Tianjin.
“By largely focusing on biomedical risk factors for diabetes, traditional research has not adequately accounted for the impact of social and cultural drivers of disease,” says David Napier, Professor of Medical Anthropology, UCL. “Our pioneering research will enable cities worldwide to help populations adapt to lifestyles that make them less vulnerable to diabetes.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7690951-study-rethink-rise-diabetes-in-cities/
The Pharmaceutical Research and Manufacturers of America (PhRMA) today released new advertising as part of its “From Hope to Cures” campaign, highlighting the stories of rare blood and lung cancer survivors.
The newest video in the collection features Matt, who was diagnosed nearly seven years ago with advanced non-small cell lung cancer. When he was diagnosed, he was given a slim chance of living up to five years. However, today Matt continues to lead an active life due to recent advancements in targeted gene therapies and innovations in cancer medicines.
The latest print and digital ads feature Jamie, a vibrant woman diagnosed 15 years ago with chronic myelogenous leukemia (CML). Watching her son grow up was a primary focus for her, and she’s been able to continue to do that and so much more. Thanks to advancements in CML treatments, today she maintains her sense of humor and imparts an infectious joy on those who meet her.
Earlier this year, the first collection of digital and print ads was released featuring Rhys, a five-year-old living with type 1 diabetes and celiac disease. Unveiled alongside the advertising was a video, titled “We’re Fighting Back,” which features both Rhys and Jamie, as well as Jen, a researcher who wakes up every day working to find new treatments and cures for patients.
To view the multimedia release go to:
http://www.multivu.com/players/English/7738431-phrma-from-hope-to-cures/
Team In Training. Light The Night. Man & Woman of the Year. Student Series. Leukemia Cup Regatta. More than 13 million participants in these popular fundraising campaigns last year alone helped The Leukemia & Lymphoma Society (LLS) invest more than $1 billion in research to advance lifesaving treatments and cures for blood cancer patients.
For Blood Cancer Awareness Month this September, LLS is reminding us that despite progress, much work still needs to be done to save more lives. More than 1.2 million people in the U.S. are living with or in remission from a blood cancer. Leukemia causes more deaths than any other cancer among children, adolescents and adults younger than 20 years. Leukemia, lymphoma and myeloma are expected to cause the deaths of an estimated 58,320 people in the U.S. in 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554853-lls-blood-cancer-awareness-month/
Today Safe Kids Worldwide released a new research report that found kids are getting into medicine at an alarming rate. Every minute of every day, a poison control center receives a call about a potential medicine poisoning for a child age five and under. And 67,000 times each year, or every eight minutes, a young child goes to the emergency room for medicine poisoning. This is a 30 percent increase over the past ten years.
In its report entitled An In-Depth Look at Keeping Young Children Safe Around Medicine, Safe Kids examines data from the U.S. Consumer Product Safety Commission, information from poison control centers and findings from several focus groups among moms. The report reviews what is happening in households that leads to these disturbing numbers and offers parents simple things they can do to protect their children.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60845-safe-kids-worldwide-keeping-young-children-safe-around-medicine
In order to succeed in today’s B2B sales world, salespeople must create buyer consensus among diverse customer stakeholders. Those who fail to do that risk falling victim to the status-quo – the minimal-risk, lowest-cost option – or worse, losing the deal altogether. The Challenger Customer: Selling to the Hidden Influencer Who Can Multiply Your Results from CEB (NYSE: CEB), a best practice insight and technology company, reveals that it isn’t just about how you engage, but who you engage within the customer organization that drives complex sales today.
“The ‘senior decision-maker’ no longer exists in B2B sales. That makes the most significant problem facing marketing and sales teams a buying problem, not a selling problem. Organizations need to shift their focus from making the sale to understanding buyer groups – and who among them really shapes decisions,” said co-author Brent Adamson, executive advisor at CEB. “Our research shows that the one thing that matters most to executives is whether or not a supplier has buy-in with the rest of the organization – NOT the supplier’s actual offering or solution.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7427252-ceb-the-challenger-customer/
This Sunday, June 19th, as we celebrate fathers across the nation, new research finds that contemporary norms of fatherhood emphasize men’s involvement with their children in addition to the traditional role of financial provider. Further, the number of hours that fathers work is not strongly related to fathers’ involvement with their children. Rather, “new fathers” appear to be cutting back on, or incorporating their children into, their leisure time.
“Over the past two decades, fathers have become more involved in all aspects of their children’s lives,” says Kenneth Braswell, National Responsible Fatherhood Clearinghouse (NRFC) Director. “Fathers continue to feel strongly about providing for their children while taking a more active role in other key activities such as meal preparation, bathing, and bedtime routines.”
Further, the Pew Research Center notes that six-in-ten Americans (58 percent) say it is “extremely important” for a father to provide values and morals to his children and roughly half say it is extremely important for a dad to provide emotional support (52 percent).
To view the multimedia release go to:
http://www.multivu.com/players/English/7858651-ad-council-nrfc-makeamoment-fatherhood-psa/
Greater Fort Lauderdale/Broward County is in the midst of unprecedented economic development, with new research revealing an influx of affluent visitors as the driving force behind new travel and hospitality-related construction and investment.
The average annual income of domestic travelers to the destination has reached $112,563 – almost 25% higher than the national average, according to a comprehensive analysis of the domestic travel market in the United States by research firm D. K. Shifflet & Associates Ltd., commissioned by the Greater Fort Lauderdale Convention & Visitors Bureau.
That is a dramatic 15.5% increase from the destination’s average in 2012 of $97,517, placing Greater Fort Lauderdale among the top leisure destinations in the U.S., and well above the national average visitor income of $90,591.
This increasing appeal to affluent travelers has led to a record-breaking 14.3 million tourists spending $11.4 billion annually in the destination, which is situated along Florida’s famed Atlantic Ocean coastline between Miami and Palm Beach.
To view the multimedia release go to:
http://www.multivu.com/players/English/7640751-greater-fort-lauderdale-development-boom/
Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that many retina specialists throughout the U.S. are now using ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema (DME). The first injections of ILUVIEN in the U.S. were captured during a live web event attended by more than 250 eye care professionals. ILUVIEN is the first multiyear eye implant designed to deliver a continuous, submicrogram daily dose of steroid to the retina for 36 months with one injection. ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7496251-iluvien-dme/
Miral and SeaWorld Entertainment, Inc. (NYSE:SEAS) (“SeaWorld”) today announced their partnership to develop SeaWorld Abu Dhabi, a first-of-its-kind marine life themed park on Yas Island. This next generation SeaWorld Abu Dhabi will also include the United Arab Emirates’ (“UAE”) first dedicated marine life research, rescue, rehabilitation and return center with world-class facilities and resources for the care and conservation of local marine life. SeaWorld Abu Dhabi will be the first new SeaWorld without orcas, and will integrate up-close animal experiences, mega attractions and a world class aquarium, bringing the latest technology in visitor engagement.
The partnership brings together Miral’s expertise in developing Yas Island’s portfolio of destinations with SeaWorld’s 50-plus years of theme park, veterinary medicine, marine science and zoological practice and experience.
To view the multimedia release go to:
http://www.multivu.com/players/uk/8002251-miral-announces-seaworld-yas-island/
Newron Pharmaceuticals S.p.A. (“Newron”), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area, announced today that the EU Committee for Medicinal Pro-ducts for Human Use (CHMP) recommended that the European Commission approve the use of Xadago™ (safinamide) as add-on to L-dopa alone or in combination with dopamine agonists, entacapone, amantadine, and/or anticholinergics, for the treatment of patients with mid-late stage Parkinson’s disease experiencing motor fluctuations despite being stabilized on ‘Standard of Care’.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7406951-chmp-xadago-parkinsons/
New research from Carfax suggests that millions of people may be driving, buying, or selling potentially dangerous cars due to an unfixed recall. The company’s annual research on the issue shows more than 46 million cars nationwide have at least one safety recall that’s never been fixed. In fact, five million of them were bought and sold by potentially unsuspecting consumers in 2014.
One of the most alarming discoveries is that people driving or buying family-oriented vehicles – specifically minivans and SUVs – are most at risk. One in three minivans and one in five SUVs has an unfixed recall, according to Carfax.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7385551-carfax-unfixed-recall-data/
New Orleans is one of the country’s most culturally, architecturally, and musically interesting cities. It will serve as the picturesque backdrop for Team Challenge, the Crohn’s & Colitis Foundation of America’s (CCFA) endurance training and fundraising program, to take over the city on February 28, 2016 for the Rock ‘n’ Roll New Orleans Marathon, Half Marathon & 10k.
For the first time ever, Team Challenge is recruiting for participants to run through the Big Easy while raising critical funds and awareness of Crohn’s disease and ulcerative colitis. Collectively known as inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis are painful, medically incurable diseases that attack the digestive system. There are more than 1.6 million Americans living with these chronic, debilitating diseases.
“Team Challenge provides people with an opportunity to raise critical research dollars while training to do something that, for many people, they never imagined they’d be able to do,” said Craig Comins, vice president of Team Challenge. “It is inspiring to see a group of people come together, some who have these diseases and some who do not, united in the mission of finding a cure for Crohn’s disease and ulcerative colitis.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7512652-ccfa-team-challenge-recruit-nola/
